Cassava Technologies may invest as much as US$720-million (R14-billion) in Africa’s first artificial intelligence factory ...

African tech firm Cassava Technologies announces plans to build the continent’s first “artificial intelligence factory,” in ...

Cassava Technologies may invest as much as $720 million in Africa’s first artificial intelligence factory that will be built ...

The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by doctors and ...

The NSWMA boss could have used far more indelicate language that few could credibly contest because our history of garbage ...

Based in the Angolan capital of Luanda, on Africa’s southwest coast, FoodCare is a dried food manufacturer that processes and ...

(Reuters) -Cassava Sciences said on Tuesday its Alzheimer's drug simufilam, which has been at the center of regulatory ...

While investigations into the drug are stopping in Alzheimer’s disease, the therapy is now being evaluated in TSC-related ...

(Reuters) -Cassava Sciences said on Tuesday it will discontinue the development of its experimental treatment simufilam for ...

Cassava Sciences has given up on simufilam in Alzheimer’s disease. | Cassava Sciences has given up on simufilam in ...

Cassava Sciences, Inc.’s SAVA share price has dipped by 20.00%, which has investors questioning if this is right time to buy.

Not least because of last week’s announcement from Cassava Technologies, a tech firm founded by Zimbabwean telecoms billionaire Strive Masiyiwa, that it would be building Africa’s first ...